急性缺血性中风中的血清生物标志物:临床应用和新兴见解
Anthi Tsogka1, John Ellul1, Elisabeth Chroni1
1Department of Neurology, University Hospital of Patras, School of Medicine, University of Patras, 26504 Patras, Greece.
Journal of clinical medicine
|November 13, 2025
概括
血清生物标志物在诊断和预测急性缺血性中风 (AIS) 的结果方面表现有前途. 虽然提供了关于炎症,损伤和凝血的见解,但它们在AIS的广泛临床使用需要进一步验证.
科学领域:
- 神经学 神经学
- 生物化学 生物化学
- 临床医学 临床医学
背景情况:
- 急性缺血性中风 (AIS) 是全球死亡和残疾的主要原因.
- 早期诊断和治疗对于有效管理AIS至关重要.
- 血清生物标志物为AIS诊断和预后提供了潜在的辅助工具.
研究的目的:
- 为AIS提供当前血清生物标志物的全面审查.
- 根据病理生理机制对生物标志物进行分类.
- 在临床实践中评估它们的诊断和预后潜力.
主要方法:
- 对AIS的血清生物标志物的现有文献进行叙述性审查.
- 根据潜在机制 (炎症,损伤,静血) 对生物标志物的分类.
- 对诊断敏感度,特异性和预后价值的评估.
主要成果:
- 生物标志物反映了炎症,氧化应激,神经元/内皮损伤和血液静止.
- 许多生物标志物在AIS中显示出诊断,预后和差异诊断的潜力.
- 预后见解包括预测并发症和功能恢复.
结论:
- 血清生物标志物对改善AIS诊断和管理具有重大前景.
- 需要进一步的研究,以克服它们在常规临床翻译中的局限性.
- 生物标志物可以帮助对AIS患者进行差异诊断和治疗监测.
关键词:
在C-RP中使用C-RP.D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D在GFAPAP中,GFAP是最重要的.这种蛋白质是Intleukin-6的.美国NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL NFL根据国家国民生产总值 (NPP) 的比例.急性缺血性中风是急性缺血性中风.纤维素原体是一种纤维原体.血清中的生物标志物这种药物是热素 (troponin).尿酸是什么 尿酸是什么相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
774
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
774
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
525
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
525
Acute Coronary Syndrome III: Diagnostic Studies
200
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
200
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
333
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
333


